APA (7th ed.) Citation

Yan, J., Liu, Z., Chen, H., Sun, X., Ge, X., & Xia, X. (2025). Real‐World Assessment of Trilaciclib for the Prevention of Chemoradiotherapy‐Induced Myelosuppression in Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study. Cancer Medicine, 14(8), 1. https://doi.org/10.1002/cam4.70862

Chicago Style (17th ed.) Citation

Yan, Jingze, Zeyuan Liu, Hui Chen, Xinchen Sun, Xiaolin Ge, and Xiaojie Xia. "Real‐World Assessment of Trilaciclib for the Prevention of Chemoradiotherapy‐Induced Myelosuppression in Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study." Cancer Medicine 14, no. 8 (2025): 1. https://doi.org/10.1002/cam4.70862.

MLA (9th ed.) Citation

Yan, Jingze, et al. "Real‐World Assessment of Trilaciclib for the Prevention of Chemoradiotherapy‐Induced Myelosuppression in Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study." Cancer Medicine, vol. 14, no. 8, 2025, p. 1, https://doi.org/10.1002/cam4.70862.